OGEN News and Press, Oragenics Inc. From 12/31/20

Are These On Your Pre New Year’s Eve Watch List? It’s the final countdown and penny stocks are, of course in the spotlight today. Whether you’re looking for new trade ideas or just a few quick flips, there’s enough going on in the stock market today to ta...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced the closing of its previously announced registered direct...

Oragenics (OGEN) enters into definitive agreements with investors for the purchase and sale of ~14.4M shares at a purchase price of $0.45 per share in a registered direct offering.Closing expected to occur on or about December 29, 2020.Total proceeds of $6.5M.Press Release For further ...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) , a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced it has entered into definitive agreements with investor...

Are These On Your Penny Stocks To Buy Or Avoid List Right Now? Are you one of the millions of new users of apps like Webull or Robinhood looking for real penny stocks to buy ? You’re not alone if you said yes. In fact, you’re among the millions of new traders flocking ...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced, the closing of its previously announced underwritten pub...

Oragenics (OGEN) plunges 28% premarket after pricing its public offering of ~14.2M common shares at $0.37/share, for expected gross proceeds of ~$5.25M.Underwriters' over-allotment is an additional 2,128,378 shares. Net proceeds will be used to fund pre-clinical development of ...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced the pricing of an underwritten public offering of 14,189...

Company name in the headline should read: Oragenics (instead of Organics) The updated release reads: ORAGENICS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) a comp...

Oragenics (OGEN) down 1% AH, has commenced a proposed underwritten public offering of common stock.Volume, price are yet to be determined. For further details see: Oragenics launches equity offering